AXTI (AXTI) Q3 2023: Gross Margin Rebounds 150bps as Data Center Signals Stabilize
AXTI’s Q3 saw signs of stabilization in core substrate markets, with a modest gross margin rebound and early traction in next-gen data center and micro-LED applications. Management remains focused on cost discipline and inventory reduction as inventory digestion persists, while new export permits and innovation initiatives lay groundwork for recovery in 2024.
Summary
- Margin Recovery: Gross margin improved sequentially as raw material mix and cost controls took hold.
- Emerging Demand: Data center and micro-LED applications are driving early new cycle signals across substrates.
- 2024 Setup: Inventory correction and export permit progress position AXTI for a potential upturn next year.
Business Overview
AXTI manufactures compound semiconductor substrates, including indium phosphide, gallium arsenide, and germanium, which are foundational materials for high-speed data communications, photonics, consumer electronics, and satellite solar cells. The company operates through both direct substrate sales and two consolidated raw material joint ventures, with revenue heavily weighted to the Asia Pacific region. AXTI’s business model depends on supplying advanced materials to leading device makers, with performance linked to end-market cycles and innovation adoption in data center, consumer, and automotive sectors.
Performance Analysis
Q3 revenue fell sharply year-over-year, reflecting the ongoing inventory digestion and cyclical downturn across key end markets. Sequentially, revenue was modestly lower, but management cited stabilization in demand, particularly in indium phosphide for data center applications. Gross margin increased to 11.3% from 9.8% in Q2, driven by improved raw material business mix and cost discipline, though it remains far below historical levels due to volume pressure and unfavorable product mix.
Operating expenses were tightly managed, holding flat quarter-over-quarter and down meaningfully from a year ago, as the company aligned spending with reduced revenue. The operating loss was nearly unchanged sequentially, but the cash balance declined due to negative operating cash flow and ongoing capital expenditures. Inventory levels were reduced by $700,000, with management targeting further reductions as a lever for future cash flow improvement.
- Substrate Mix Shifts: Indium phosphide revenue stabilized, while gallium arsenide and germanium showed incremental improvement following new export permits.
- Raw Material Margin Uptick: Gross margin in the raw material joint ventures improved, partially offsetting volume-driven pressure in core substrates.
- Inventory Rationalization: Inventory drawdown is underway but remains at elevated levels relative to current revenue run rate.
Overall, the quarter marked a bottoming process, with management emphasizing early signs of demand recovery and operational flexibility as key to weathering the cyclical trough.
Executive Commentary
"The demand environment in Q3 remains stable, and we were pleased to see some encouraging early signs of improvement in the data center market, resulting in modest higher Indian phosphide revenues. We still believe that inventory digestion across our markets will continue to the end of the year, and in some cases may persist into 2024. But we believe the worst of the declines are behind us."
Dr. Morris Young, Chief Executive Officer
"With the reduction in overall revenue, we have maintained spending discipline in our operating expenses to align with the current environment. ... Beyond the near term, we remain confident that we can get back to the mid-30% range as the environment strengthens through higher overall volume, more favorable product mix, and the benefits of our recycling programs, along with continued efficiency improvements throughout our business."
Gary Fisher, Chief Financial Officer
Strategic Positioning
1. Data Center and Silicon Photonics Tailwind
Indium phosphide, a high-speed optical substrate, is seeing renewed development activity as data centers prepare to move to 800 gig data rates and next-gen silicon photonics. Management highlighted ongoing customer engagement and validation of six-inch substrates, positioning AXTI as a strategic supplier for future device cycles. Early adoption in AI-driven infrastructure is a potential multi-year catalyst.
2. Micro-LED and Display Innovation
Gallium oxide substrates, targeting micro-LED and automotive displays, are progressing through stringent customer qualification. While ramp timelines have slipped, management cited firm customer commitment and expects initial volume production to begin in mid-2025. This segment offers a long-term growth vector as wearable and automotive display requirements intensify.
3. Export Permit Progress and Geographic Diversification
Tongmei, AXTI’s China subsidiary, secured initial export permits for gallium arsenide and germanium substrates, enabling resumed shipments and reducing customer disruption. Management continues to work through the permitting process, which remains a gating factor for full recovery in these segments. Asia Pacific remains the dominant revenue source, but export flexibility is critical for serving global customers.
4. Cost Structure and Inventory Leverage
Cost discipline remains a top priority, with operating expenses held flat and a focus on inventory reduction to support working capital and future profitability. Management sees further opportunity to shrink inventory by at least $10 million, which would bolster cash flow as demand normalizes.
5. IPO Pathway for Tongmei
Listing Tongmei on the STAR Market in Shanghai is an ongoing initiative, with one open item remaining. Management remains confident in approval prospects and views the IPO as a potential source of liquidity and strategic flexibility.
Key Considerations
This quarter’s results illustrate AXTI’s navigation through a cyclical low point, while laying the groundwork for recovery through innovation, operational discipline, and regulatory progress. The company’s strategic bets on next-generation data center and display applications are starting to gain traction, but the timing and magnitude of recovery remain uncertain given persistent inventory overhang and macro volatility.
Key Considerations:
- Data Center Cycle Reacceleration: Indium phosphide demand is stabilizing, with AI and higher-speed optical devices offering a structural growth lever.
- Export Permit Bottleneck: Progress in obtaining new permits is essential for restoring full revenue potential in gallium arsenide and germanium.
- Micro-LED Ramp Timing: Customer commitment is clear, but production volume and ramp speed remain uncertain into 2025.
- Inventory and Cash Flow Management: Further inventory reduction is critical for restoring positive operating cash flow and supporting liquidity.
- Tongmei IPO Optionality: STAR Market listing could provide capital and validate AXTI’s China growth platform.
Risks
AXTI faces ongoing risks from cyclical end-market weakness, persistent inventory digestion, and regulatory hurdles in China that impact export flexibility. The company’s reliance on a narrow set of advanced substrate applications exposes it to shifts in technology adoption and customer concentration. Uncertainties around the timing of micro-LED and next-gen data center ramps, as well as execution on cost and inventory reduction, remain key watchpoints for investors.
Forward Outlook
For Q4 2023, AXTI guided to:
- Revenue between $16 million and $19 million
- Non-GAAP net loss of $0.13 to $0.15 per share
- GAAP net loss of $0.15 to $0.17 per share
For full-year 2023, management did not provide updated annual guidance, but reiterated:
- Inventory digestion likely to persist into early 2024
- Cost control and working capital discipline remain top priorities
Management highlighted several factors that will shape the near-term trajectory:
- Export permit progress could unlock incremental substrate shipments
- Next-gen data center and micro-LED development activity is expected to build into 2024
Takeaways
AXTI’s Q3 results reflect a business in transition, with early signals of stabilization in core substrate markets and a renewed focus on operational discipline as the company positions for a cyclical upturn.
- Margin Inflection Point: Sequential gross margin improvement signals early benefit from product mix and cost actions, but full recovery depends on volume normalization.
- Strategic Innovation Bets: Progress in data center and micro-LED substrates positions AXTI for exposure to secular growth themes, though ramp timing is extended.
- Monitor Inventory and Export Dynamics: Investors should watch for further inventory drawdown, cash flow stabilization, and regulatory progress as leading indicators of recovery.
Conclusion
AXTI’s Q3 marked a stabilization phase, with incremental progress on margin, cost control, and export flexibility. The company’s innovation pipeline and disciplined execution provide a credible setup for recovery, but investors should remain attuned to inventory, regulatory, and ramp risks heading into 2024.
Industry Read-Through
AXTI’s results reinforce the broader semiconductor substrate industry’s cyclical pattern, with inventory digestion and regulatory complexity weighing on near-term growth. The early signs of recovery in data center optical demand and micro-LED qualification are relevant for peers supplying advanced photonics and display materials, as AI and high-speed connectivity drive new adoption cycles. Export permit challenges and inventory management are likely to remain industry-wide themes, especially for suppliers with significant exposure to China. The timing of next-gen device ramps and end-market normalization will be a key determinant of sector performance in 2024.